Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: differences between children and adults.

Lipshultz SE, Wilkinson JD.

Eur Heart J. 2014 Jan;35(1):10-2. doi: 10.1093/eurheartj/ehs402. Epub 2012 Dec 2. No abstract available.

PMID:
23209259
2.

Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.

Miyamoto SD, Stauffer BL, Nakano S, Sobus R, Nunley K, Nelson P, Sucharov CC.

Eur Heart J. 2014 Jan;35(1):33-41. doi: 10.1093/eurheartj/ehs229. Epub 2012 Jul 26.

3.

Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.

Gilbert EM, O'Connell JB, Bristow MR.

Heart Vessels Suppl. 1991;6:29-39. Review.

PMID:
1687924
4.

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR.

N Engl J Med. 2002 May 2;346(18):1357-65.

5.

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.

Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J, et al.

Circulation. 1991 Sep;84(3):1024-39.

PMID:
1653120
6.

Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.

Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, Guillet JG, Strosberg AD, Hjalmarson A, Hoebeke J.

J Clin Invest. 1990 Nov;86(5):1658-63.

7.

Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy.

White M, Yanowitz F, Gilbert EM, Larrabee P, O'Connell JB, Anderson JL, Renlund D, Mealey P, Abraham WT, Bristow MR.

Am J Cardiol. 1995 Dec 15;76(17):1271-6.

PMID:
7503009
8.

Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.

Forleo C, Sorrentino S, Guida P, Romito R, De Tommasi E, Iacoviello M, Pitzalis M.

J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):589-95.

PMID:
17667029
9.

Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.

Forleo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V, Romito R, Iacoviello M, De Tommasi E, Troisi F, Rizzon B, Guanti G, Rizzon P, Pitzalis MV.

Am J Med. 2004 Oct 1;117(7):451-8.

PMID:
15464701
10.

[Familial idiopathic dilated cardiomyopathy - search for identity].

Tendera M.

Kardiol Pol. 2009 Mar;67(3):242. Polish. No abstract available.

PMID:
19469061
11.

Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.

Paczkowska A, Szperl M, Małek Ł, Mazurkiewicz Ł, Skóra E, Grzybowski J, Roszczynko M, Bilińska Z, Tesson F, Ruzyłło W.

Kardiol Pol. 2009 Mar;67(3):235-41.

12.

Meta-analysis of the use of low-dose beta-adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathy.

Zarembski DG, Nolan PE Jr, Slack MK, Lui CY.

Am J Cardiol. 1996 Jun 1;77(14):1247-50.

PMID:
8651108
13.

[Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy].

Shinke T, Takaoka H, Takeuchi M, Hata K, Kawai H, Okubo H, Kijima Y, Murata T, Yokoyama M.

J Cardiol. 2001 Feb;37(2):119-20. Japanese.

PMID:
11255696
14.

Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).

Anthonio RL, Brouwer J, Lechat P, Haaksma J, van der Ven L, van Veldhuisen DJ, Crijns HJ, van Gilst WH.

Am J Cardiol. 1999 Apr 15;83(8):1286-9, A10.

PMID:
10215303
15.

Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.

Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF.

Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.

16.

Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience.

Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM, Lemes V.

J Heart Lung Transplant. 1999 Mar;18(3):269-74.

PMID:
10328154
17.

Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.

Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1898-905. Epub 2006 Dec 8.

18.

High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities.

Chiale PA, Rosenbaum MB, Elizari MV, Hjalmarson A, Magnusson Y, Wallukat G, Hoebeke J.

J Am Coll Cardiol. 1995 Oct;26(4):864-9.

19.

Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.

Jahns R, Boivin V, Lohse MJ.

Int J Cardiol. 2006 Sep 10;112(1):7-14. Epub 2006 Jul 26. Review.

PMID:
16872696
20.

Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' heart disease.

Rosenbaum MB, Chiale PA, Schejtman D, Levin M, Elizari MV.

J Cardiovasc Electrophysiol. 1994 Apr;5(4):367-75. Review.

PMID:
8019712

Supplemental Content

Support Center